With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...

A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

If you have hyperkalemia, you have high levels of potassium in your blood. If you don’t get your potassium under control, the condition can be life-threatening. That’s why it’s important to advocate ...

ST. GALLEN, Switzerland, Sept. 24, 2024 /PRNewswire/ -- CSL Vifor today announced that Japan's Ministry of Health and Labor Welfare (MHLW) has granted its partner, Zeria Pharmaceutical Co., Ltd.

Deep brain stimulation (DBS) has shown promise as a treatment for some symptoms of Parkinson s disease (PD). However, not all symptoms improve equally well with DBS. A better understanding of how ...

It can be administered orally or in an enema. ANI Pharmaceuticals announced the launch of Kionex ® (sodium polystyrene sulfonate suspension USP) for Oral or Rectal Use for the treatment of ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

When doctors decide on a course of treatment, they have a lot of data to inform their decision-making. But they do not always have the time to interpret that data. University of Washington Chair of ...